Evidence map›Paper›PMID 35732272›Full record

ArticleThe international journal of neuropsychopharmacology2022

Positive Allosteric Modulation of α5-GABAA Receptors Reverses Stress-Induced Alterations in Dopamine System Function and Prepulse Inhibition of Startle.

Alexandra M McCoy, Thomas D Prevot, Md Yenus Mian, James M Cook, Alan Frazer, Etienne L Sibille, Flavia R Carreno, Daniel J Lodge

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Enantiomer-specific modulation of GABAPsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An alpha 5-GABAAutism research : official journal of the International Society for Autism Research · 2024
    Article
  11. Article
  12. GABATrends in pharmacological sciences · 2023
    Review
  13. GL-II-73, a Positive Allosteric Modulator of α5GABAInternational journal of molecular sciences · 2023
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Alexandra M McCoyDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0002-8449-7717
Thomas D PrevotCampbell Family Mental Health Research Institute of CAMH, Toronto, ON, Canada.ORCID 0000-0002-6774-603X
Md Yenus MianDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
James M CookDepartment of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Alan FrazerDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, Texas, USA.
Etienne L SibilleCampbell Family Mental Health Research Institute of CAMH, Toronto, ON, Canada.
Flavia R CarrenoDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, Texas, USA.
Daniel J LodgeDepartment of Pharmacology and Center for Biomedical Neuroscience, UT Health San Antonio, San Antonio, Texas, USA.
The University of Texas Health Science Center at San Antonio · USUniversity of Toronto · CAUniversity of Wisconsin–Milwaukee · US

Funding

Regulation of ventral hippocampal system functionR01MH090067 · NIMH · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LODGE, DANIEL · 2010 to 2019
$3.5M
Integrated Graduate Training Program in Neuroscience, UTHSCSAT32NS082145 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI David A Morilak · 2013 to 2026
$1.5M
Selective negative allosteric modulators of alpha 5-GABAA receptors: novel psychotherapeutic drugsI01BX000559 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI MORILAK, DAVID A · 2011 to 2025
–
Mechanisms contributing to co-morbid psychosis in Alzheimer's diseaseI01BX004646 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI LODGE, DANIEL · 2021 to 2024
–
The Orexin System as a Target for PTSD and Comorbid PsychosisI01BX004693 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI Daniel Lodge · 2020 to 2026
–
BLRD VA I01 BX000559BLRD VA I01 BX004646BLRD VA I01 BX004693NIMH NIH HHS R01 MH090067NINDS NIH HHS T32 NS082145
6 · The paper itself

Abstract

backgroundUp to 64% of patients diagnosed with posttraumatic stress disorder (PTSD) experience psychosis, likely attributable to aberrant dopamine neuron activity. We have previously demonstrated that positive allosteric modulators of α5-GABAARs can selectively decrease hippocampal activity and reverse psychosis-like physiological and behavioral alterations in a rodent model used to study schizophrenia; however, whether this approach translates to a PTSD model remains to be elucidated.

methodsWe utilized a 2-day inescapable foot shock (IS) procedure to induce stress-related pathophysiology in male Sprague-Dawley rats. We evaluated the effects of intra-ventral hippocampus (vHipp) administration GL-II-73, an α5-GABAAR, or viral overexpression of the α5 subunit, using in vivo electrophysiology and behavioral measures in control and IS-treated rats.

resultsIS significantly increased ventral tegmental area dopamine neuron population activity, or the number of dopamine neurons firing spontaneously (n = 6; P = .016), consistent with observation in multiple rodent models used to study psychosis. IS also induced deficits in sensorimotor gating, as measured by reduced prepulse inhibition of startle (n = 12; P = .039). Interestingly, intra-vHipp administration of GL-II-73 completely reversed IS-induced increases in dopamine neuron population activity (n = 6; P = .024) and deficits in prepulse inhibition (n = 8; P = .025), whereas viral overexpression of the α5 subunit in the vHipp was not effective.

conclusionsOur results demonstrate that pharmacological intervention augmenting α5-GABAAR function, but not α5 overexpression in itself, can reverse stress-induced deficits related to PTSD in a rodent model, providing a potential site of therapeutic intervention to treat comorbid psychosis in PTSD.

Indexed as

DopamineReceptors, GABA-AStress, PsychologicalAllosteric RegulationAnimalsHippocampusMalePrepulse InhibitionRatsRats, Sprague-DawleyDopamineGabra5 protein, ratReceptors, GABA-Apositive allosteric modulatorspsychosisPTSDventral hippocampusα5-GABAA receptor

Identifiers

PMID35732272
PMCPMC9380714
OpenAlexW4283317879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.